Vascular surgery claim denials and appeals: the CARC-by-CARC guide.
Vascular surgery denials cluster around five reason codes, and each one has a real appeal argument only when the underlying facts support it — a bundling denial with a modifier indicator of 0, or a missing-authorization denial where the authorization genuinely doesn't cover the territory billed, are not appealable no matter how the letter is worded. This is our vascular surgery denials and appeals guide: the CARC-by-CARC breakdown, the full appeal-letter structure, and the specific prior-authorization failure pattern — requesting or billing a second territory speculatively — that generates more preventable denial volume in this specialty than any single coding error.
Key takeaways
- Requesting or billing a second territory speculatively — iliac plus femoropopliteal when only one is imaging-confirmed — is the single largest source of preventable prior-auth denial volume in vascular surgery. It's a scheduling and documentation fix, not a coding fix.
- Two indicator values decide whether a bundling or unit-cap denial can even be appealed — the NCCI modifier indicator (0 versus 1) and the MUE Adjudication Indicator (2 versus 3). Check both before a single letter gets written.
- CO-197/CO-15 (no authorization on file) is the weakest appeal position in the specialty. If the authorization genuinely doesn't match the service performed, the fix is a corrected claim or a peer-to-peer, not a standard appeal.
- Naming the specific LCD article and MAC by ID — not a generic "per Medicare" reference — is the difference between an appeal that gets read and one that gets form-denied a second time.
Why vascular surgery denies the way it does
Vascular surgery stacks three denial-prone patterns on top of each other: interventions that legitimately span more than one anatomic territory in a single session, diagnosis codes that Medicare LCDs treat as hard coverage gates rather than formalities, and a prior-authorization process built around a single planned procedure that struggles with a surgeon's real-time intraoperative findings. None of that is unique to vascular surgery individually, but the combination is, and it shows up in the denial mix: bundling denials from multi-territory claims, medical-necessity denials from diagnosis codes that don't match a MAC's covered list, and authorization denials from a claim that doesn't match what was actually approved. Each has a real fix, and none of them is "write a better-worded appeal letter" — the fix is almost always upstream, at order entry or scheduling, not at the appeal desk.
The CARC-by-CARC breakdown
Pairing the denial code with the actual appeal argument, not just the generic reason, is what separates a claim that gets overturned from one that gets form-denied a second time on reconsideration.
| Denial | Why it fires | Appeal argument | Prevention |
|---|---|---|---|
| CO-50 Not medically necessary | The diagnosis on the claim isn't on the MAC's published covered-condition list for that intervention, or the severity level (claudication, rest pain, tissue loss) documented doesn't match what the policy requires alongside an ABI value | Name the specific article and MAC — for example Palmetto GBA's endovascular PAD article, A60247 — and attach both the ABI value and the functional severity documentation the policy actually asks for, plus the specific ICD-10 code (e.g. I70.229 rest pain or I70.269 gangrene rather than unspecified atherosclerosis) | Check the covered-condition list at order entry, before the study or intervention, not after the denial |
| CO-97 Bundled into another service | The billed code is a column 2 component of a code already paid on the claim — 36901 billed alongside 36902/36903 is the textbook example, and multi-territory LER add-ons trigger it too | Only appealable if the pair's NCCI modifier indicator is 1, not 0 — confirm the indicator first in the CMS NCCI PTP Edits Lookup Tool, then appeal with the operative note showing the second service was a genuinely separate territory or structure | Run the pair through the scrubber before submission; don't rely on the claim clearinghouse to catch it after the fact |
| CO-197 / CO-15 No prior authorization on file | The service performed doesn't match what the authorization actually covers — most often an additional territory billed beyond what was pre-approved | The weakest position in the specialty. If the authorization genuinely doesn't cover the service, appeal rarely succeeds; a corrected claim scoped to the authorized territory, or a peer-to-peer for the unauthorized portion, is the realistic path | Confirm the authorization names the exact territory and CPT range planned before the case is scheduled — see the speculative-request pattern below |
| CO-151 Frequency | A duplex or physiologic study billed for a territory before the once-per-year window (or its pre-op/post-op/inpatient exception) has elapsed | Confirm the exception actually applies and cite it by name; otherwise this isn't a true appeal — rebill once the patient is eligible | Track study, territory, and date centrally at order entry rather than relying on staff memory or a spreadsheet |
| CO-4 Modifier missing or invalid | Laterality (50/RT/LT) or component (26/TC) modifier is absent or doesn't match the site of service billed | Rebill with the correct modifier — this is a claim correction, not an appeal, in almost every case | Map each service to its default laterality and component convention by payer in the charge master, not case by case |
The iliac-plus-femoral speculative billing trap
This is the pattern behind more preventable vascular surgery denial volume than any other single cause, and it's specific enough to name directly. A patient is worked up and authorized for femoropopliteal intervention — the pre-procedure duplex or CTA shows significant femoropopliteal stenosis, and the authorization request and approval are scoped to that territory and its code range (37263–37279). During the case, the surgeon crosses into the iliac system, sees what looks like a lesion worth treating, and either treats it in the same session or documents it as a planned second step — and staff bill an iliac code (37254–37262) alongside the femoral code on the same claim, without the authorization, and often without the pre-procedure imaging, actually establishing iliac disease.
The claim doesn't just deny the iliac line. Because the two territories now sit on the same claim and the same operative note, payers frequently pull the femoral line into medical review too, turning one preventable denial into a delayed payment on the line that was actually correct. The root cause isn't a coding error — the codes are right for what was done — it's a documentation and authorization mismatch: the claim reflects what happened in the OR, but the authorization reflects what was planned before the OR, and nobody reconciled the two before the claim went out.
- Scope the prior-authorization request to only the territories the pre-procedure imaging actually documents as diseased.
- When a second territory is found intraoperatively and treated, flag the claim for a same-day or urgent authorization request or a peer-to-peer before it's billed — not after the denial arrives.
- Document severity and lesion detail separately for each territory in the operative note, even when both are treated in one session.
- Don't request or list a second territory on the authorization "in case it's needed" without imaging support for it.
- Don't bill an unauthorized second territory on the same claim as the authorized one and hope it processes — it usually drags the authorized line into review with it.
- Don't treat this as a coding problem to fix with a modifier; XS documents that a service was distinct, it doesn't manufacture an authorization that was never requested.
Structuring the appeal letter
A vascular surgery appeal that gets overturned on the first pass follows the same structure regardless of which CARC triggered it, and skipping any one of these steps is usually why a technically correct appeal gets form-denied on reconsideration anyway.
- 1Lead with identifiers, not narrative. Patient name, member ID, claim number, date of service, and the specific denied CPT/HCPCS line — in the first two lines, before any argument.
- 2Name the denial code and cite the specific policy by ID. "CO-50 per LCD/Article A60247, Palmetto GBA" carries weight; "not medically necessary per Medicare policy" does not.
- 3State the clinical fact that satisfies the policy, in the policy's own terms. If the article requires an ABI value plus a functional-severity category, state both explicitly rather than assuming the attached chart makes the connection for the reviewer.
- 4Attach the supporting documentation as labeled exhibits. Operative note, imaging report, authorization confirmation number, and (for a bundling appeal) the specific NCCI modifier indicator or MAI value that makes the override valid.
- 5State the requested action and the timeline. For Medicare Part B, a first-level redetermination request is generally due within 120 days of the initial determination; name the level of appeal being requested and don't let the letter read as a vague protest.
Before drafting any bundling or unit-cap appeal, look up the NCCI modifier indicator and the MUE Adjudication Indicator for the specific code pair in the CMS lookup tools. If either comes back non-appealable — indicator 0, or MAI 2 — stop. There is no letter that changes that outcome, and the time is better spent on the CO-50 and CO-197 claims that are actually winnable.
Frequently asked questions
Why do vascular surgery prior authorization denials keep happening on multi-territory interventions?
The most common pattern is a speculative request: staff or the surgeon list both an iliac code and a femoropopliteal code on the authorization or the claim when the pre-procedure imaging only actually established disease in one territory, on the assumption the second territory might also need treatment once the surgeon is inside the vessel. Payers authorize what the imaging supports, not what might be found, so the un-supported territory denies as CO-197/CO-15 or CO-50 and sometimes drags the supported territory into medical review with it. Request and bill only the territories the pre-procedure study actually documents, and treat an unexpected second territory found intra-procedure as a distinct workflow, not a same-claim add-on.
Can we appeal a CO-97 bundling denial in vascular surgery?
Only if the NCCI modifier indicator on that specific column 1/column 2 pair is 1, not 0. An indicator of 0 means the second code is never separately payable regardless of documentation, and an appeal against it is wasted staff time. An indicator of 1 means an NCCI-associated modifier can override the edit, but only where the record shows the second service was genuinely separate — a different vascular territory, a different session, or a different structure — so confirm the indicator first, then build the appeal around the specific documentation that supports the distinction.
What's the difference between an MUE denial we can appeal and one we can't?
The MUE Adjudication Indicator, or MAI, decides it. MAI 2 is an absolute, date-of-service edit CMS treats as clinically implausible; there is no appeal path, full stop, no matter how well documented the excess units were. MAI 3 is a date-of-service edit that can be appealed with documentation showing the excess units reflect genuinely distinct sessions or territories. MAI 1 is a claim-line edit where a real repeat service can often just be split across separate lines with the correct modifier rather than appealed at all. Confirm the MAI before staff spend time writing anything.
Vascular surgery denials eating into your collections?
We'll audit a sample of your recent denials, tell you which ones are actually appealable and which aren't, and fix the upstream authorization and documentation gaps causing the rest.
Verify before billing. CPT is a registered trademark of the American Medical Association; codes here are paraphrased, not reproduced from the CPT Professional edition. CPT, HCPCS and ICD-10 codes, coverage policy, and bundling edits change, including annual code-set updates. This page reflects standard industry practice and is provided for general education — it is not a substitute for your own compliance review, your current payer contracts, or the current-year code sets. Confirm requirements against your specific payer mix before submitting claims.